Hyperglycosylated human chorionic gonadotropin as a predictor of ongoing pregnancy.

[1]  C. Racowsky,et al.  Making evidence-based decisions in reproductive medicine. , 2018, Fertility and sterility.

[2]  E. Knochenhauer,et al.  Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort , 2017, Journal of Assisted Reproduction and Genetics.

[3]  J. Kwak‐Kim,et al.  Serum hCG-β levels of postovulatory day 12 and 14 with the sequential application of hCG-β fold change significantly increased predictability of pregnancy outcome after IVF-ET cycle , 2016, Journal of Assisted Reproduction and Genetics.

[4]  Jemma Evans.  Hyperglycosylated hCG: a Unique Human Implantation and Invasion Factor , 2016, American journal of reproductive immunology.

[5]  L. Salamonsen,et al.  Dynamic changes in hyperglycosylated human chorionic gonadotrophin throughout the first trimester of pregnancy and its role in early placentation. , 2015, Human reproduction.

[6]  G. Garzo,et al.  Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization. , 2012, Fertility and sterility.

[7]  U. Stenman,et al.  First trimester hyperglycosylated human chorionic gonadotrophin in serum - a marker of early-onset preeclampsia. , 2013, Placenta.

[8]  Neeta Singh,et al.  Predictive value of early serum beta-human chorionic gonadotrophin for the successful outcome in women undergoing in vitro fertilization , 2013, Journal of human reproductive sciences.

[9]  J. Knez,et al.  Human chorionic gonadotropin levels are equally predictive for pregnancy outcome after fresh and vitrified-warmed blastocyst transfer , 2013, Journal of Assisted Reproduction and Genetics.

[10]  J. Foidart,et al.  Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF‐β receptor activation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Iles,et al.  Human Chorionic Gonadotropin (hCG) in the Secretome of Cultured Embryos , 2013, Reproductive Sciences.

[12]  D. Schomberg,et al.  Hyperglycosylated human chorionic gonadotropin does not increase progesterone production by luteinized granulosa cells. , 2012, The Journal of clinical endocrinology and metabolism.

[13]  C. Strom,et al.  The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer , 2012, Journal of Assisted Reproduction and Genetics.

[14]  Y. Cruz-Almeida,et al.  Prognostic value of beta-human chorionic gonadotropin is dependent on day of embryo transfer during in vitro fertilization. , 2011, Fertility and sterility.

[15]  J. Guibourdenche,et al.  Hyperglycosylated hCG is a marker of early human trophoblast invasion. , 2010, The Journal of clinical endocrinology and metabolism.

[16]  L. Cole,et al.  Hyperglycosylated hCG, a review. , 2010, Placenta.

[17]  P. Saunders,et al.  Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. , 2009, Endocrinology.

[18]  S. Nakajima,et al.  Age and a single day-14 β-HCG can predict ongoing pregnancy following IVF , 2009 .

[19]  L. Cole,et al.  Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. , 2008, Fertility and sterility.

[20]  N. Bersinger,et al.  Serum Hyperglycosylated Human Chorionic Gonadotropin to Predict the Gestational Outcome in in vitro Fertilization/Intracytoplasmic Sperm Injection Pregnancies , 2008, Fetal Diagnosis and Therapy.

[21]  B. Huppertz.  Placental Origins of Preeclampsia: Challenging the Current Hypothesis , 2008, Hypertension.

[22]  K. Barnhart,et al.  Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy. , 2006, Fertility and sterility.

[23]  F. Byrn,et al.  A single serum test for measuring early pregnancy outcome with high predictive value. , 2006, Clinical biochemistry.

[24]  K. Barnhart,et al.  Defining the rise of serum HCG in viable pregnancies achieved through use of IVF. , 2006, Human reproduction.

[25]  S. Lydersen,et al.  Serious foetal growth restriction is associated with reduced proportions of natural killer cells in decidua basalis , 2006, Virchows Archiv.

[26]  Z. Rosenwaks,et al.  Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. , 2005, Fertility and sterility.

[27]  S. Robson,et al.  Inhibition of Trophoblast Cell Invasion by TGFB1, 2, and 3 Is Associated with a Decrease in Active Proteases1 , 2005, Biology of reproduction.

[28]  S. Birken.  Specific Measurement of O-Linked Core 2 Sugar-Containing Isoforms of Hyperglycosylated Human Chorionic Gonadotropin by Antibody B152 , 2005, Tumor Biology.

[29]  P. Lam,et al.  GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. , 2005, Human reproduction.

[30]  K. Barnhart,et al.  Symptomatic Patients With an Early Viable Intrauterine Pregnancy: hCG Curves Redefined , 2004, Obstetrics and gynecology.

[31]  D. Evain-Brion,et al.  A comparison of placental development and endocrine functions between the human and mouse model. , 2003, Human reproduction update.

[32]  V. Hiilesmaa,et al.  Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. , 2002, Human reproduction.

[33]  M. Sauer,et al.  Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. , 2002, The Journal of endocrinology.

[34]  D. Kniss,et al.  Characterization of a TGFβ-responsive human trophoblast-derived cell line , 2001 .

[35]  L. Cole,et al.  Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. , 2001, Clinical chemistry.

[36]  A. Campana,et al.  Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy. , 2000, Human reproduction.

[37]  D. Gardner,et al.  Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. , 2000, Fertility and sterility.

[38]  D. Gardner,et al.  Culture and transfer of human blastocysts. , 1999, Current opinion in obstetrics & gynecology.

[39]  E. Surrey,et al.  Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. , 1998, Fertility and sterility.

[40]  J Hilden,et al.  Regret graphs, diagnostic uncertainty and Youden's Index. , 1996, Statistics in medicine.

[41]  J. Nisker,et al.  Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization. , 1992, Fertility and sterility.

[42]  S Greenland,et al.  The impact of confounder selection criteria on effect estimation. , 1989, American journal of epidemiology.

[43]  R. Akhurst,et al.  Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. , 1988, Human reproduction.